ASO Author Reflections: The Gustave Roussy Immune Score May Be a Useful Biomarker for Conversion Surgery After Chemotherapy Plus Nivolumab as the First-Line Treatment for Gastric Cancer.
Saved in:
| Title: | ASO Author Reflections: The Gustave Roussy Immune Score May Be a Useful Biomarker for Conversion Surgery After Chemotherapy Plus Nivolumab as the First-Line Treatment for Gastric Cancer. |
|---|---|
| Authors: | Nakazawa N; Department of General Surgical Science, Graduate School of Medicine, Gunma University, Maebashi, Japan. nakazawa75@yahoo.co.jp., Sano A; Department of General Surgical Science, Graduate School of Medicine, Gunma University, Maebashi, Japan., Sakai M; Department of General Surgical Science, Graduate School of Medicine, Gunma University, Maebashi, Japan., Shirabe K; Department of General Surgical Science, Graduate School of Medicine, Gunma University, Maebashi, Japan., Saeki H; Department of General Surgical Science, Graduate School of Medicine, Gunma University, Maebashi, Japan. |
| Source: | Annals of surgical oncology [Ann Surg Oncol] 2024 Dec; Vol. 31 (13), pp. 9052-9053. Date of Electronic Publication: 2024 Sep 17. |
| Publication Type: | Journal Article; Multicenter Study |
| Journal Info: | Publisher: Springer Country of Publication: United States NLM ID: 9420840 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1534-4681 (Electronic) Linking ISSN: 10689265 NLM ISO Abbreviation: Ann Surg Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
